Microbot Medical Inc (NASDAQ:MBOT) reached a new 52-week low on Monday . The stock traded as low as $1.71 and last traded at $1.82, with a volume of 16300 shares trading hands. The stock had previously closed at $2.12.
MBOT has been the subject of several research reports. ValuEngine upgraded shares of Microbot Medical from a “hold” rating to a “buy” rating in a research report on Thursday, September 6th. LADENBURG THALM/SH SH lowered shares of Microbot Medical from a “buy” rating to a “hold” rating and set a $1.75 target price on the stock. in a research note on Monday, November 19th. They noted that the move was a valuation call. Finally, Zacks Investment Research lowered shares of Microbot Medical from a “hold” rating to a “sell” rating in a research note on Saturday, September 22nd.
Microbot Medical (NASDAQ:MBOT) last released its quarterly earnings data on Wednesday, November 14th. The biotechnology company reported ($0.58) earnings per share for the quarter, topping the consensus estimate of ($0.60) by $0.02.
TRADEMARK VIOLATION NOTICE: “Microbot Medical (MBOT) Sets New 12-Month Low at $1.71” was first posted by WKRB News and is owned by of WKRB News. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international copyright laws. The original version of this article can be viewed at https://www.wkrb13.com/2018/11/27/microbot-medical-mbot-sets-new-12-month-low-at-1-71.html.
Microbot Medical Inc, a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob and TipCAT micro-robotic technologies, is developing two product candidates, including the Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and a self-propelling, semi-disposable endoscope, which is used in colonoscopy procedures.
Recommended Story: What is Depreciation?
Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.